欧洲肝脏研究学会肝硬化腹水、自发性细菌性腹膜炎和肝肾综合征管理临床实践指南 - Suppr

Suppr

超能文献

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

出版信息

J Hepatol. 2010 Sep;53(3):397-417. doi: 10.1016/j.jhep.2010.05.004. Epub 2010 Jun 1.

DOI:10.1016/j.jhep.2010.05.004

PMID:20633946

Abstract

摘要

相似文献

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.欧洲肝脏研究学会肝硬化腹水、自发性细菌性腹膜炎和肝肾综合征管理临床实践指南

J Hepatol. 2010 Sep;53(3):397-417. doi: 10.1016/j.jhep.2010.05.004. Epub 2010 Jun 1.

Management of adult patients with ascites due to cirrhosis: an update.肝硬化所致成人腹水患者的管理：最新进展

Hepatology. 2009 Jun;49(6):2087-107. doi: 10.1002/hep.22853.

Management of cirrhosis and ascites.肝硬化和腹水的管理

N Engl J Med. 2004 Apr 15;350(16):1646-54. doi: 10.1056/NEJMra035021.

Management of ascites.腹水的管理

Clin Liver Dis. 2001 May;5(2):541-68, viii. doi: 10.1016/s1089-3261(05)70177-x.

Management of cirrhotic ascites.肝硬化腹水的管理

Br J Hosp Med (Lond). 2015 Feb;76(2):C28-32. doi: 10.12968/hmed.2015.76.2.C28.

Minimizing ascites. Complication of cirrhosis signals clinical deterioration.尽量减少腹水。肝硬化并发症预示着临床病情恶化。

Postgrad Med. 2001 Feb;109(2):91-6, 101-3. doi: 10.3810/pgm.2001.02.854.

β-blockers and refractory ascites in cirrhosis: the message of a team of true scientists.β受体阻滞剂与肝硬化难治性腹水：一群真正科学家传递的信息

J Hepatol. 2011 Oct;55(4):743-4. doi: 10.1016/j.jhep.2011.02.026. Epub 2011 Mar 10.

Diagnosis and management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome.腹水、自发性细菌性腹膜炎和肝肾综合征的诊断与管理

Cleve Clin J Med. 2023 Apr 3;90(4):209-213. doi: 10.3949/ccjm.90a.22028.

Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis.肝硬化患者的腹水和自发性细菌性腹膜炎

Scand J Gastroenterol Suppl. 2006(243):79-84. doi: 10.1080/00365520600664342.

Ascites and Hepatorenal Syndrome.腹水和肝肾综合征。

Clin Liver Dis. 2019 Nov;23(4):659-682. doi: 10.1016/j.cld.2019.06.002. Epub 2019 Aug 7.

引用本文的文献

COMPARING THE PREDICTIVE EFFICACY OF MELD AND ALBI SCORES IN LIVER CIRRHOSIS PATIENTS WITH ACUTE UPPER GASTROINTESTINAL BLEEDING.比较MELD评分与ALBI评分对肝硬化合并急性上消化道出血患者的预测效能

Arq Gastroenterol. 2025 Sep 5;62:e24075. doi: 10.1590/S0004-2803.24612024-075. eCollection 2025.

Clinical, Microbiological, and Antibiotic Treatment Characteristics of Bacterial Infections in Patients with Liver Cirrhosis in China: A Multicenter Study.中国肝硬化患者细菌感染的临床、微生物学及抗生素治疗特征：一项多中心研究

J Clin Transl Hepatol. 2025 Aug 28;13(8):644-654. doi: 10.14218/JCTH.2025.00211. Epub 2025 Jul 3.

Impacts of salt restriction on nutritional status, sarcopenia, and mortality of cirrhotic patients with ascites.限盐对肝硬化腹水患者营养状况、肌肉减少症和死亡率的影响。

BMC Gastroenterol. 2025 Jul 15;25(1):521. doi: 10.1186/s12876-025-03830-1.

Palliative long-term abdominal drains vs. large volume paracentesis for refractory ascites secondary to cirrhosis: protocol for a definitive randomised controlled trial (REDUCe2 study).姑息性长期腹腔引流与大量腹腔穿刺术治疗肝硬化继发性难治性腹水的比较：一项确定性随机对照试验方案（REDUCe2研究）

Trials. 2025 Jun 4;26(1):193. doi: 10.1186/s13063-025-08873-z.

Role of oral Midodrine in preventing hepatorenal syndrome in Child-Turcotte-Pugh class C cirrhotics: a pilot study.口服米多君在预防Child-Turcotte-Pugh C级肝硬化患者肝肾综合征中的作用：一项初步研究。

Gastroenterol Hepatol Bed Bench. 2024;17(4):438-449. doi: 10.22037/ghfbb.v17i4.3019.

Clinical Outcomes and Microbiological Profiles of Patients with Culture-Confirmed Peritonitis.培养确诊的腹膜炎患者的临床结局和微生物学特征

Infect Dis Clin Microbiol. 2025 Mar 27;7(1):88-96. doi: 10.36519/idcm.2025.539. eCollection 2025 Mar.

Hepatorenal Syndrome: direct treatment costs and characteristics of patients admitted to intensive care.肝肾综合征：重症监护病房收治患者的直接治疗费用及特征

Einstein (Sao Paulo). 2025 Apr 7;23:eGS0390. doi: 10.31744/einstein_journal/2025GS0390. eCollection 2025.

Comments on "duct-related complications of pediatric post-traumatic pancreatitis": Expanding the discussion.关于“小儿创伤后胰腺炎的导管相关并发症”的评论：拓展讨论

Int J Surg Case Rep. 2025 Apr;129:111078. doi: 10.1016/j.ijscr.2025.111078. Epub 2025 Feb 24.

Host FSTL1 defines the impact of stem cell therapy on liver fibrosis by potentiating the early recruitment of inflammatory macrophages.宿主FSTL1通过增强炎症巨噬细胞的早期募集来定义干细胞疗法对肝纤维化的影响。

Signal Transduct Target Ther. 2025 Mar 7;10(1):81. doi: 10.1038/s41392-025-02162-6.

Diagnostic value of vascular endothelial growth factor (VEGF) levels in gastrointestinal cancers with ascites - A cross sectional study.血管内皮生长因子（VEGF）水平在伴有腹水的胃肠道癌中的诊断价值——一项横断面研究。

Turk J Surg. 2025 Feb 27;41(1):78-84. doi: 10.47717/turkjsurg.2025.6592.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验